Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MASON, Malcolm")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care?MASON, Malcolm.Journal of cancer research and clinical oncology. 2006, Vol 132, issn 0171-5216, S27-S35, SUP1Article

The interaction between β-catenin, GSK3β and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancerDAVIES, Gaynor; JIANG, Wen G; MASON, Malcolm D et al.International journal of oncology. 2001, Vol 18, Num 4, pp 843-847, issn 1019-6439Article

Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells : A key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasionDAVIES, Gaynor; JIANG, Wen G; MASON, Malcolm D et al.Clinical cancer research. 2001, Vol 7, Num 10, pp 3289-3297, issn 1078-0432Article

Cell adhesion molecules and adhesion abnormalities in prostate cancerMASON, Malcolm D; DAVIES, Gaynor; JIANG, Wen G et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 1, pp 11-28, issn 1040-8428Article

Understanding the impact of public policy on cancer research: A bibliometric approachLEWISON, Grant; PURUSHOTHAM, Arnie; MASON, Malcolm et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 912-919, issn 0959-8049, 8 p.Article

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialWARDE, Padraig; MASON, Malcolm; BARBER, Jim et al.Lancet (British edition). 2011, Vol 378, Num 9809, pp 2104-2111, issn 0140-6736, 8 p.Article

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate CancerMOTTET, Nicolas; BELLMUNT, Joaquim; HEIDENREICH, Axel et al.European urology. 2011, Vol 59, Num 4, pp 572-583, issn 0302-2838, 12 p.Article

Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesotheliomaJASANI, Bharat; COLEMAN, Sharon; BUTCHART, Eric et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2399-2402, issn 0264-410X, 4 p.Conference Paper

A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder CancerMEEKS, Joshua J; BELLMUNT, Joaquim; STERNBERG, Cora N et al.European urology. 2012, Vol 62, Num 3, pp 523-533, issn 0302-2838, 11 p.Article

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancerDE BONO, Johann Sebastian; BELLMUNT, Joaquim; COCKEY, Louise et al.Journal of clinical oncology. 2007, Vol 25, Num 3, pp 257-262, issn 0732-183X, 6 p.Article

Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancerSUN, Ping-Hui; LIN YE; MASON, Malcolm D et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 7, pp 1129-1139, issn 0171-5216, 11 p.Article

The influence of matriptase-2 on prostate cancer in vitro: A possible role for β-cateninWEBB, Siobhan L; SANDERS, Andrew J; MASON, Malcolm D et al.Oncology reports. 2012, Vol 28, Num 4, pp 1491-1497, issn 1021-335X, 7 p.Article

Gemcitabine chemotherapy for the treatment of metastatic bladder carcinomaSHELLEY, Michael D; CLEVES, Anne; WILT, Timothy J et al.BJU international (Papier). 2011, Vol 108, Num 2, pp 168-179, issn 1464-4096, 12 p.Article

Cancer Exosomes Trigger Fibroblast to Myofibroblast DifferentiationWEBBER, Jason; STEADMAN, Robert; MASON, Malcolm D et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9621-9630, issn 0008-5472, 10 p.Article

The role of surgery in high-risk localised prostate cancerGNANAPRAGASAM, Vincent J; MASON, Malcolm D; SHAW, Greg L et al.BJU international (Papier). 2012, Vol 109, Num 5, pp 648-658, issn 1464-4096, 11 p.Article

EPLIN is a Negative Regulator of Prostate Cancer Growth and InvasionSANDERS, Andrew J; MARTIN, Tracey A; LIN YE et al.The Journal of urology. 2011, Vol 186, Num 1, pp 295-301, issn 0022-5347, 7 p.Article

The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cellsJIANG, Wen G; LIN YE; ABLIN, Richard J et al.International journal of oncology. 2010, Vol 37, Num 2, pp 413-418, issn 1019-6439, 6 p.Article

Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathwayJIANG, Wen G; LIN YE; KE JI et al.International journal of oncology. 2012, Vol 41, Num 5, pp 1635-1642, issn 1019-6439, 8 p.Article

Increased exosome production from tumour cell cultures using the Integra CELLine Culture SystemMITCHELL, J. Paul; COUN, Jacqueline; MASON, Malcolm David et al.Journal of immunological methods. 2008, Vol 335, Num 1-2, pp 98-105, issn 0022-1759, 8 p.Article

The Clinical Management of Patients With a Small Volume of Prostatic Cancer on Biopsy : What Are the Risks of Progression? A Systematic Review and Meta-analysisHARNDEN, Patricia; NAYLOR, Brian; SHELLEY, Michael D et al.Cancer. 2008, Vol 112, Num 5, pp 971-981, issn 0008-543X, 11 p.Article

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancerCOLEMAN, Sharon; CLAYTON, Aled; MASON, Malcolm D et al.Cancer research (Baltimore). 2005, Vol 65, Num 15, pp 7000-7006, issn 0008-5472, 7 p.Article

HAVcR-1 Reduces the Integrity of Human Endothelial Tight JunctionsMARTIN, Tracey A; HARRISON, Gregory M; MASON, Malcolm D et al.Anticancer research. 2011, Vol 31, Num 2, pp 467-473, issn 0250-7005, 7 p.Article

Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic reviewSHELLEY, Mike D; JONES, Gabriel; CLEVES, Anne et al.BJU international (Papier). 2012, Vol 109, Num 4, pp 496-505, issn 1464-4096, 10 p.Article

Phospholipase-C gamma-1 (PLCy-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cellsDAVIES, Gaynor; MARTIN, Tracey A; LIN YE et al.Urologic oncology. 2008, Vol 26, Num 4, pp 386-391, issn 1078-1439, 6 p.Article

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinomaSKYRME, Rob J; FRENCH, A. Jane; DATTA, Shibendra N et al.BJU international (Papier). 2005, Vol 95, Num 9, pp 1206-1210, issn 1464-4096, 5 p.Article

  • Page / 2